An Infectious Disease-Associated Il12b Polymorphism Regulates IL-12/23 p40 Transcription Involving Poly(ADP- Ribose) Polymerase 1

被引:6
|
作者
Zhao, Quanju [1 ]
Du, Qinglin [1 ]
Wei, Fang [1 ]
Xie, Jianping [2 ]
Ma, Xiaojing [1 ,3 ]
机构
[1] Shanghai Jiao Tong Univ, Sch Life Sci & Biotechnol, Sheng Yushou Ctr Cell Biol & Immunol, State Key Lab Microbial Metab, Shanghai 200240, Peoples R China
[2] Southwest Univ, State Key Lab Breeding Base Ecoenvironm & Bioreso, Key Lab Ecoenvironm Three Gorges Reservoir Reg, Minist Educ,Sch Life Sci,Inst Modern Biopharmaceu, Chongqing 400715, Peoples R China
[3] Weill Cornell Med Coll, Dept Microbiol & Immunol, New York, NY 10065 USA
来源
JOURNAL OF IMMUNOLOGY | 2017年 / 198卷 / 07期
基金
美国国家卫生研究院;
关键词
NF-KAPPA-B; CEREBRAL MALARIA; GENE-EXPRESSION; PROMOTER POLYMORPHISM; BINDING; MACROPHAGES; ACTIVATION; PARP-1; CELLS; ELEMENTS;
D O I
10.4049/jimmunol.1601894
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
IL-12 and IL-23 are important host defense factors produced by APCs against certain intracellular and extracellular pathogens. Their dysregulation has also been implicated in several autoimmune diseases. The nucleotide polymorphism in the promoter region of Il12b (rs41292470 consisting of the long or short allele) encoding the shared subunit of IL-12 and IL-23, p40, has been reported to associate with susceptibility to infectious diseases and autoimmune disorders. How these genetic variants impact Il12b expression at the molecular level was unclear. We established an Il12b promoter-luciferase reporter system containing the long or short allele driving the reporter gene expression and found that the long allele (infection-resistant) displayed-2-fold higher transcriptional activity than the short allele (infection-susceptible), associated with a selective and differential nuclear binding activity to the two alleles in activated macrophages. DNA pull-down assays coupled with mass spectrometry analyses identified the specific DNA binding activity as poly(ADP-ribose) polymerase 1 (PARP-1). Small hairpin RNA-mediated knockdown of the endogenous PARP-1 expression resulted in reduced p40 mRNA expression and Il12b promoter activity. Bone marrow-derived macrophages from PARP-1-deficient mice had decreased p40 expression at both mRNA and protein levels. Furthermore, selective PARP-1 inhibitors resulted in impaired production of IL-12p40 and IL-23 in bone-marrow derived macrophages and PBMCs. Chromatin immunoprecipitation assay revealed that PARP-1 could bind specifically to Il12b in LPS-stimulated macrophages. Our study opens the way for further elucidating the molecular mechanism whereby allele-specific immune responses to foreign and selfantigens mediated by IL-12/ IL-23 are controlled in an individually variable manner.
引用
收藏
页码:2935 / 2942
页数:8
相关论文
共 49 条
  • [1] Psoriasis is not associated with IL-12p70/IL-12p40 production and IL12B promoter polymorphism
    Litjens, NHR
    van der Plas, MJA
    Ravensbergen, B
    Numan-Ruberg, SC
    van Assen, Y
    Thio, HB
    van Dissel, JT
    van de Vosse, E
    Nibbering, PH
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2004, 122 (04) : 923 - 926
  • [2] The inflammatory disease-associated variants in IL12B and IL23R are not associated with rheumatoid arthritis
    Chang, Monica
    Saiki, Randall K.
    Cantanese, Joseph J.
    Lew, David
    van der Helm-van Mil, Annette H. M.
    Toes, Rene E. M.
    Huizinga, Thomas W. J.
    Ardlie, Kristin G.
    Criswell, Lindsey A.
    Seldin, Michael F.
    Amos, Christopher I.
    Kastner, Daniel L.
    Gregersen, Peter K.
    Schrodi, Steven J.
    Begovich, Ann B.
    ARTHRITIS AND RHEUMATISM, 2008, 58 (06): : 1877 - 1881
  • [3] The autoimmune disease-associated IL12B and IL23R polymorphisms in multiple sclerosis
    Begovich, Ann B.
    Chang, Monica
    Caillier, Stacy J.
    Lew, David
    Catanese, Joseph J.
    Wang, Joanne
    Hauser, Stephen L.
    Oksenberg, Jorge R.
    HUMAN IMMUNOLOGY, 2007, 68 (11) : 934 - 937
  • [4] Lack of association of IL-12 p40 gene polymorphism with peptic ulcer disease
    García-González, MA
    Lanas, A
    Wu, J
    Benito, R
    Santolaria, S
    Crusius, B
    Peña, S
    HUMAN IMMUNOLOGY, 2005, 66 (01) : 72 - 76
  • [5] Genetic polymorphism of IL-12 p40 gene in immune-mediated disease
    Hall, MA
    McGlinn, E
    Coakley, G
    Fisher, SA
    Boki, K
    Middleton, D
    Kaklamani, E
    Moutsopoulos, H
    Loughran, TP
    Ollier, WER
    Panayi, GS
    Lanchbury, JS
    GENES AND IMMUNITY, 2000, 1 (03) : 219 - 224
  • [6] Genetic polymorphism of IL-12 p40 gene in immune-mediated disease
    MA Hall
    E McGlinn
    G Coakley
    SA Fisher
    K Boki
    D Middleton
    E Kaklamani
    H Moutsopoulos
    TP Loughran
    WER Ollier
    GS Panayi
    JS Lanchbury
    Genes & Immunity, 2000, 1 : 219 - 224
  • [7] Lack of association of interleukin-12 p40 gene (IL12B) polymorphism with Behcet's disease in the Japanese population
    Yanagihori, H
    Tojo, M
    Inoue, T
    Nakamura, K
    Kaneko, F
    Nishida, T
    Mizuki, N
    JOURNAL OF DERMATOLOGICAL SCIENCE, 2004, 34 (02) : 112 - 114
  • [8] The influence of JNK and P38 MAPK inhibition on IL-12P40 and IL-23 production depending on IL12B promoter polymorphism
    Zlatka Georgieva Dobreva
    Spaska Angelova Stanilova
    Lyuba Dineva Miteva
    Cellular & Molecular Biology Letters, 2009, 14 : 609 - 621
  • [9] The influence of JNK and P38 MAPK inhibition on IL-12P40 and IL-23 production depending on IL12B promoter polymorphism
    Dobreva, Zlatka Georgieva
    Stanilova, Spaska Angelova
    Miteva, Lyuba Dineva
    CELLULAR & MOLECULAR BIOLOGY LETTERS, 2009, 14 (04) : 609 - 621
  • [10] Interleukin-12 p40 gene (IL12B) 3′-untranslated region polymorphism is associated with susceptibility to atopic dermatitis and psoriasis vulgaris
    Tsunemi, Y
    Saeki, H
    Nakamura, K
    Sekiya, T
    Hirai, K
    Fujita, H
    Asano, N
    Kishimoto, M
    Tanida, Y
    Kakinuma, T
    Mitsui, H
    Tada, Y
    Wakugawa, M
    Torii, H
    Komine, M
    Asahina, A
    Tamaki, K
    JOURNAL OF DERMATOLOGICAL SCIENCE, 2002, 30 (02) : 161 - 166